Linkages of innate and adaptive immunity.

The innate immune system is activated by pathogens or environmental antigens following their binding by recognition molecules such as mannan-binding lectin, C-reactive protein and the mannose receptor. Natural antibody, which represents a collection of germline-encoded antigen recognition molecules, is also important in recognition of pathogens and activation of the innate immune system via the classical pathway of complement activation. The major source of natural antibody is CD5+ B-1 cells which differ from conventional B cells (B-2 cells) firstly because they are thought to require contact with antigen for expansion and maintenance and secondly because in general they do not appear to undergo somatic hypermutation. We review results which support an important role for complement in maintenance of B-1 cells, the effect being mediated by B cell expression of complement receptors CD21 and CD35. We propose that complement and natural antibody are interdependent: clonal selection and expansion of CD5+ B-1 cells is dependent on contact with antigen coated by the complement component C3d, while efficient recognition of pathogens and activation of complement is dependent in a large part on natural antibody. This hypothesis is supported by the finding that mice deficient in CD21 and CD35 have a reduced number of CD5+ B-1 cells and are missing specificities for certain antigens commonly found in wild-type mice, such as lipopolysaccharide, Escherichia coli surface antigens and neoepitopes expressed on hypoxic intestinal endothelium.

[1]  M. Weiser,et al.  Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement , 1996, The Journal of experimental medicine.

[2]  S. Smith‐Gill,et al.  Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. , 1992, Journal of immunology.

[3]  K. Reid,et al.  The proteolytic activation systems of complement. , 1981, Annual review of biochemistry.

[4]  G. Kelsoe The germinal center reaction. , 1995, Immunology today.

[5]  S. Clarke,et al.  Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. , 1988, Journal of immunology.

[6]  L. Herzenberg,et al.  The Ly-1 B cell lineage. , 1986, Immunological reviews.

[7]  J. Ahearn,et al.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.

[8]  G. Kelsoe,et al.  Antibody response to a T-dependent antigen requires B cell expression of complement receptors , 1996, The Journal of experimental medicine.

[9]  R. Hardy,et al.  Distinctive Developmental Origins and Specificities of Murine CD5+ B Cells , 1994, Immunological reviews.

[10]  Christopher C. Goodnow,et al.  C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity , 1996, Science.

[11]  S. Christensen,et al.  The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. , 1990, Journal of immunology.

[12]  G. Kelsoe,et al.  In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self- tolerance , 1995, The Journal of experimental medicine.

[13]  R. Karr,et al.  Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Fearon,et al.  Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. , 1997, Immunity.

[15]  L. Arnold,et al.  Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline , 1989, The Journal of experimental medicine.

[16]  B. Echtenacher,et al.  Critical protective role of mast cells in a model of acute septic peritonitis , 1996, Nature.

[17]  C. Goodnow Transgenic mice and analysis of B-cell tolerance. , 1992, Annual review of immunology.

[18]  S. Galli,et al.  Impaired mast cell-dependent natural immunity in complement C3-deficient mice , 1997, Nature.

[19]  D. Fearon,et al.  The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. , 1995, Annual review of immunology.

[20]  B. Koller,et al.  Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. , 1995, Immunity.

[21]  S. Sheriff,et al.  The collectins in innate immunity. , 1996, Current opinion in immunology.

[22]  L. Herzenberg,et al.  The LY‐1B Cell Lineage , 1986 .

[23]  V. Nussenzweig,et al.  Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1). , 1985, Journal of immunology.

[24]  Kenneth G. C. Smith,et al.  Soluble antigen can cause enhanced apoptosis of germinal-centre B cells , 1995, Nature.

[25]  J. Volanakis,et al.  C-reactive protein , 1997, Immunologic research.

[26]  H. Müller-Eberhard,et al.  Molecular organization and function of the complement system. , 1988, Annual review of biochemistry.

[27]  Liangji Zhou,et al.  The CD19/CD21 signal transduction complex of B lymphocytes. , 1994, Immunology today.

[28]  D. Fearon,et al.  CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. , 1992, Science.

[29]  R. Hardy,et al.  Self‐renewal of B‐1 lymphocytes is dependent on CD19 , 1996, European journal of immunology.

[30]  J. Strominger,et al.  Identification of murine complement receptor type 2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Herzenberg,et al.  B-cell lineages exist in the mouse. , 1993, Immunology today.

[32]  R. V. van Lier,et al.  Dual antigen recognition by B cells. , 1993, Immunology today.

[33]  G. Kelsoe In situ studies of the germinal center reaction. , 1995, Advances in immunology.

[34]  D. Tuveson,et al.  The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. , 1991, Journal of immunology.

[35]  V. Holers,et al.  A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. , 1990, Journal of immunology.

[36]  F. Rosen,et al.  Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. , 1997, Journal of immunology.

[37]  E. Kremmer,et al.  Regulation of the B cell response to T-dependent antigens by classical pathway complement. , 1996, Journal of immunology.

[38]  J. Murrow,et al.  Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. , 1997, Journal of immunology.

[39]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[40]  T. Tedder,et al.  Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. , 1991, Journal of immunology.

[41]  K. Shokat,et al.  Antigen-induced B-cell death and elimination during germinal-centre immune responses , 1995, Nature.

[42]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[43]  S. Levy,et al.  The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. , 1992, Journal of immunology.

[44]  Klaus Rajewsky,et al.  Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice , 1995, Nature.